J Clin Endocrinol Metab 2022 Apr 22. Epub 2022 Apr 22.
Division of Endocrinology and Metabolism, Department of Medicine, University of California, San Francisco, 513 Parnassus Ave., HSE901, San Francisco, CA.
Purpose: Heterotopic ossification (HO) is a process by which bone forms abnormally in soft tissues. Known risk factors for developing HO include male sex, spinal cord injury, trauma, and surgery. We investigated additional risk factors in the development of HO after hip arthroplasty.
Methods: We performed a retrospective review of electronic medical records of 4070 individuals who underwent hip arthroplasty from September 2010 to October 2019 at the University of California, San Francisco Hospital. Demographics, anthropometrics, medications, and comorbid conditions were used in logistic regression analysis to identify factors associated with the development of HO.
Results: 2541 patients underwent primary hip arthroplasty in the analyzed timeframe (46.04% men, mean age at procedure: 62.13±13.29 years). The incidence of post-surgical HO was 3% (n=80). A larger proportion of individuals who developed HO had underlying osteoporosis (p<0.001), vitamin D deficiency (p<0.001), spine disease (p<0.001), Type 1 or 2 diabetes (p<0.001), amenorrhea (p=0.037), post-menopausal status (p<0.001), parathyroid disorders (p=0.011), and history of pathologic fracture (p=0.005). Significant predictors for HO development were African American race (OR 2.97, p=0.005), pre-existing osteoporosis (OR 2.72, p=0.001), spine disease (OR 2.04, p=0.036) and low estrogen states (OR 1.99, p=0.025). In the overall group, 75.64% received peri-operative non-steroidal anti-inflammatory drugs (NSAIDs), which negatively correlated with HO formation (OR 0.39, p=0.001).
Conclusions: We identified new factors potentially associated with an increased risk of developing HO after primary hip arthroplasty, including African American race, osteoporosis, and low estrogen states. These patients may benefit from HO prophylaxis, such as peri-operative NSAIDs.